Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1302

1.

Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.

Shields CL, Bas Z, Tadepalli S, Dalvin LA, Rao R, Schwendeman R, Lally SE, Shields JA, Shah A, Leahey A.

Br J Ophthalmol. 2020 Feb 12. pii: bjophthalmol-2019-315572. doi: 10.1136/bjophthalmol-2019-315572. [Epub ahead of print]

PMID:
32051141
2.
3.

BAP1 Germline Mutation Associated with Bilateral Primary Uveal Melanoma.

Yu MD, Masoomian B, Shields JA, Shields CL.

Ocul Oncol Pathol. 2020 Jan;6(1):10-14. doi: 10.1159/000499570. Epub 2019 Jun 4.

PMID:
32002398
4.

UVEAL METASTASIS BASED ON PATIENT AGE IN 1,111 PATIENTS: Comparison of Clinical Features and Outcomes Per Age Category.

Shields CL, Acaba-Berrocal LA, Selzer EB, Mayro EL, Newman JH, Malik K, Welch RJ, Shields JA.

Retina. 2020 Feb;40(2):204-213. doi: 10.1097/IAE.0000000000002364.

PMID:
31972789
5.

Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture.

Shields CL, Khoo CTL, Mazloumi M, Mashayekhi A, Shields JA.

Ophthalmol Retina. 2019 Oct 28. pii: S2468-6530(19)30604-9. doi: 10.1016/j.oret.2019.10.009. [Epub ahead of print]

PMID:
31953111
6.

Conjunctival 'mucoepidermoid carcinoma' revisited: a revision of terminology, based on morphologic, immunohistochemical and molecular findings of 14 cases, and the 2018 WHO Classification of Tumours of the Eye.

Mudhar HS, Milman T, Zhang PJL, Shields CL, Eagle RC, Lally SE, Shields JA, Salvi SM, Rundle PA, Tan J, Rennie IG.

Mod Pathol. 2020 Jan 13. doi: 10.1038/s41379-020-0456-9. [Epub ahead of print]

PMID:
31932683
7.

An Outcome Assessment of a Single Institution's Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis.

Seedor RS, Eschelman DJ, Gonsalves CF, Adamo RD, Orloff M, Amjad A, Sharpe-Mills E, Chervoneva I, Shields CL, Shields JA, Mastrangelo MJ, Sato T.

Cancers (Basel). 2020 Jan 1;12(1). pii: E117. doi: 10.3390/cancers12010117.

8.

CHOROIDAL NEOVASCULAR MEMBRANE AFTER FINE-NEEDLE ASPIRATION BIOPSY OF VITREORETINAL LYMPHOMA.

Mashayekhi A, Mazloumi M, Shields CL, Shields JA.

Retin Cases Brief Rep. 2019 Dec 27. doi: 10.1097/ICB.0000000000000933. [Epub ahead of print]

PMID:
31895085
9.

Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals.

Shields CL, Dalvin LA, Chang M, Mazloumi M, Fortin P, McGarrey M, Martin A, Yaghy A, Yang X, Vichitvejpaisal P, Mashayekhi A, Shields JA.

JAMA Ophthalmol. 2019 Dec 12. doi: 10.1001/jamaophthalmol.2019.5132. [Epub ahead of print]

PMID:
31830238
10.

Ultra-low-dose (boom-boom) radiotherapy for choroidal lymphoma in three consecutive cases.

Yang X, Dalvin LA, Lim LS, Mashayekhi A, Shields JA, Shields CL.

Eur J Ophthalmol. 2019 Nov 24:1120672119888985. doi: 10.1177/1120672119888985. [Epub ahead of print]

PMID:
31760781
11.

Malignant transformation of choroidal nevus according to race in 3334 consecutive patients.

Marous CL, Shields CL, Yu MD, Dalvin LA, Ancona-Lezama D, Shields JA.

Indian J Ophthalmol. 2019 Dec;67(12):2035-2042. doi: 10.4103/ijo.IJO_1217_19.

12.

Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.

Shields CL, Dalvin LA, Vichitvejpaisal P, Mazloumi M, Ganguly A, Shields JA.

Indian J Ophthalmol. 2019 Dec;67(12):1959-1963. doi: 10.4103/ijo.IJO_1589_19. Review.

13.

Melanocytoma of the optic disk: A review.

Shields JA, Demirci H, Mashayekhi A, Eagle RC Jr, Shields CL.

Indian J Ophthalmol. 2019 Dec;67(12):1949-1958. doi: 10.4103/ijo.IJO_2039_19. Review.

14.

Tumors of the conjunctiva and cornea.

Shields CL, Shields JA.

Indian J Ophthalmol. 2019 Dec;67(12):1930-1948. doi: 10.4103/ijo.IJO_2040_19. Review.

15.

From Lepidoptera to uveal melanoma: Finding my career in ocular oncology.

Shields JA.

Indian J Ophthalmol. 2019 Dec;67(12):1922-1923. doi: 10.4103/ijo.IJO_1587_19. No abstract available.

16.

Representing Communication, Compassion, and Competence in the Era of AI.

Yaghy A, Shields JA, Shields CL.

AMA J Ethics. 2019 Nov 1;21(11):E1009-1013. doi: 10.1001/amajethics.2019.1009.

17.

Uveal metastasis in 1111 patients: Interval to metastasis and overall survival based on timing of primary cancer diagnosis.

Welch RJ, Malik K, Mayro EL, Newman JH, Honig SE, Ang SM, Selzer EB, Acaba-Berrocal LA, McGarrey MP, Graf AE, Considine SP, Shields JA, Shields CL.

Saudi J Ophthalmol. 2019 Jul-Sep;33(3):229-237. doi: 10.1016/j.sjopt.2019.07.006. Epub 2019 Jul 25.

18.

Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases.

Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA, Shields CL.

Saudi J Ophthalmol. 2019 Jul-Sep;33(3):219-228. doi: 10.1016/j.sjopt.2019.07.002. Epub 2019 Jul 16.

19.

Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases.

Shields CL, Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA.

Ophthalmol Retina. 2020 Jan;4(1):100-110. doi: 10.1016/j.oret.2019.08.004. Epub 2019 Aug 22.

PMID:
31611094
20.

Eyelid chalazion or not?

Shields JA, Lally SE, Milman T, Shields CL.

Indian J Ophthalmol. 2019 Oct;67(10):1519. doi: 10.4103/ijo.IJO_1620_19. No abstract available.

Supplemental Content

Loading ...
Support Center